Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review.
about
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsClinical utility of dabigatran in United Arab Emirates. A pharmacovigilance study.Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis.
P2860
Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Stop the clots, but at what co ...... systematic literature review.
@en
type
label
Stop the clots, but at what co ...... systematic literature review.
@en
prefLabel
Stop the clots, but at what co ...... systematic literature review.
@en
P2093
P2860
P356
P1476
Stop the clots, but at what co ...... systematic literature review.
@en
P2093
Jesse Dawson
Patricia Fearon
Sarah Marshall
Terence J Quinn
P2860
P356
10.1586/ERP.12.79
P577
2013-02-01T00:00:00Z